gut microbiota metabolism of l-carnitine and cardiovascular risk

gut microbiota metabolism of l-carnitine and cardiovascular risk A Disease-Linked Microbial Metabolite Acts via Adrenergic Receptors: Cell Cardiovascular risk of dietary trimethylamine

Name: gut microbiota metabolism of l-carnitine and cardiovascular risk A Disease-Linked Microbial Metabolite Acts via Adrenergic Receptors: Cell Cardiovascular risk of dietary trimethylamine
Brand: reganhouse.co.nz
SKU: 15896555013
Price: 20.20 USD
Availability: InStock
Rating: 4.846 (14 reviews)

Cardiovascular risk of dietary trimethylamine oxide precursors and the therapeutic potential of resveratrol and its derivatives Hou 2024 FEBS Open Bio Wiley Online Library Gut microbiota and microbiota derived metabolites in cardiovascular diseases Chinese Medical Journal Diet gut microbiota interactions on cardiovascular disease ScienceDirect Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship Microbiota in GutHeart Axis: Metabolites and Mechanisms in Cardiovascular Disease Kondapalli 2025 Comprehensive Physiology Wiley Online Library Gut microbiota metabolism of l carnitine and cardiovascular risk Atherosclerosis

SKU: 15896555013 · From reganhouse.co.nz

4.8

USD20.20 USD41.20

Pay in 4 interest-free payments of $5.05 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

Root Architecture The plant root system accounts for 80% of the whole plant, which not only anchors the plant into the soil, but also finds, uptakes, and transports nutrient

Ambion) served as positive control

In both Bax / and Bak1 / MEFs, B-017 displayed protection against staurosporine-induced apoptosis (Fig

doi: 10.1371/journal.pone.0105328 30 PorntharukchareonT.DechatesB.SirisreetreeruxS.TherawitP.TawinpraiK

Methylcobalamin (Vitamin B12) An active form of vitamin B12 that supports energy production, nervous system function, and cognitive health

Upregulation of MDR1 and induction of doxorubicin resistance by synergistic use of histone deacetylase inhibitor depsipeptide (FK228) and ATRA in acute promyelocytic leukemia cells